BeOne Medicines Ltd.
Close on Nov 2, 2026Market cap $41.08BP/E 64.6Yield –
BeOne Medicines Share-Based Compensation by Year
Share-Based Compensation — Research & Development ($M) ($M)
BeOne Medicines Share-Based Compensation: $217M in FY2025, up 16.8% from a year earlier. That is the highest of the 11 years on record here.
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-26) ↗
Reported in Form 10-Q / 10-K Share-Based Compensation Note (XBRL).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Share-Based Compensation — Research & Development ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 217 | +16.8% | Form 10-K (filed 2026-02-26) ↗ |
| FY2024 | Dec 31, 2024 | 186 | +13.8% | Form 10-K (filed 2026-02-26) ↗ |
| FY2023 | Dec 31, 2023 | 164 | +17.4% | Form 10-K (filed 2026-02-26) ↗ |
| FY2022 | Dec 31, 2022 | 139 | +21.8% | Form 10-K (filed 2025-02-27) ↗ |
| FY2021 | Dec 31, 2021 | 114 | +23.0% | Form 10-K (filed 2024-02-26) ↗ |
| FY2020 | Dec 31, 2020 | 93 | +21.9% | Form 10-K (filed 2023-02-27) ↗ |
| FY2019 | Dec 31, 2019 | 76.3 | +40.3% | Form 10-K (filed 2022-02-28) ↗ |
| FY2018 | Dec 31, 2018 | 54.4 | +77.8% | Form 10-K (filed 2021-02-25) ↗ |
| FY2017 | Dec 31, 2017 | 30.6 | +277.8% | Form 10-K (filed 2020-03-02) ↗ |
| FY2016 | Dec 31, 2016 | 8.10 | -15.6% | Form 10-K (filed 2019-02-28) ↗ |
| FY2015 | Dec 31, 2015 | 9.60 | – | Form 10-K (filed 2018-02-28) ↗ |
Cite this data
StockData. (2026). BeOne Medicines Share-Based Compensation ($M), annual FY2015–FY2025 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/sbc-rd
See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.